Cefepime Induced Encephalopathy Mimicking Acute Stroke
- Author:
Young Il KIM
1
;
Subum HWANG
;
Byoungchul CHOI
;
Jeongsu HWANG
;
Sang Hwa LEE
Author Information
- Publication Type:Case Report
- Keywords: Cefepime; Encephalopathy; Stroke
- MeSH: Aged, 80 and over; Brain Diseases; Female; Humans; Myoclonus; Seizures; Stroke; United States Food and Drug Administration
- From:Journal of the Korean Neurological Association 2019;37(4):372-375
- CountryRepublic of Korea
- Language:Korean
- Abstract: Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.
